AstraZeneca AB v Alphapharm Pty Ltd [2014] FCA 9
AstraZeneca did not have sufficient information within r 7.23(1)(b) to decide whether to commence a proceeding for threatened infringement of AU839 because the material provided did not enable it to determine with sufficient confidence whether the Alphapharm API was crystalline or partly crystalline at some stage, whether the hydrate was a trihydrate, and its relevant water content. Further documents identified by Dr Luk would assist in making that decision, and Alphapharm advanced no discretionary reason to refuse discovery once the rule's requirements were satisfied. However, delivery of samples was not justified at this stage because, before further information was provided, the Court...
- Jurisdiction
- Australia
- Judgment Date
- 23 January 2014
- Procedural Posture
- Application for Pre Action Discovery Under R 7.23 of the Federal Court Rules 2011 (cth) / Amended Originating Application for Discovery and Inspection of Documents and Delivery of Samples in Relation to a Potential Proceeding for Threatened Patent Infringement
- Outcome
- The Amended Originating Application was adjourned to a date to be fixed for the making of an order or orders consistent with the reasons. The Court indicated that an order in terms of paragraph 1 for discovery and inspection should be made, subject to further matters, but that the sample delivery order in paragraph...
- Legal Topics
- ['pre Action Discovery' 'prospective Patent Infringement Proceeding' 'sufficiency of Information to Decide Whether to Start a Proceeding' 'discovery and Inspection of Documents' 'delivery of Samples' 'confidential Pharmaceutical Regulatory Documents']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Application for Pre Action Discovery Under R 7.23 of the Federal Court Rules 2011 (cth) / Amended Originating Application for Discovery and Inspection of Documents and Delivery of Samples in Relation to a Potential Proceeding for Threatened Patent Infringement
Legal Issues
- 1 ['Whether AstraZeneca, after making reasonable inquiries, had sufficient information to decide whether to start a proceeding in the Court for threatened infringement of AU839 within r 7.23(1)(b) of the Federal Court Rules 2011 (Cth).' 'Whether documents sought in paragraph 1 of the Amended Originating Application should be ordered to be discovered and inspected.' 'Whether samples of the Alphapharm Products should be ordered to be delivered under s 23 of the Federal Court of Australia Act 1976 (Cth).' "Whether any order for discovery should be adjusted to include confidentiality undertakings or otherwise accommodate Alphapharm's advice about use of the Launch API."]
Ratio Decidendi
AstraZeneca did not have sufficient information within r 7.23(1)(b) to decide whether to commence a proceeding for threatened infringement of AU839 because the material provided did not enable it to determine with sufficient confidence whether the Alphapharm API was crystalline or partly crystalline at some stage, whether the hydrate was a trihydrate, and its relevant water content. Further documents identified by Dr Luk would assist in making that decision, and Alphapharm advanced no discretionary reason to refuse discovery once the rule's requirements were satisfied. However, delivery of samples was not justified at this stage because, before further information was provided, the Court...
Court Disposition
The Amended Originating Application was adjourned to a date to be fixed for the making of an order or orders consistent with the reasons. The Court indicated that an order in terms of paragraph 1 for discovery and inspection should be made, subject to further matters, but that the sample delivery order in paragraph...
Orders
- ['The Amended Originating Application be adjourned to a date to be fixed for the making of an order or orders on the application consistent with these reasons.']
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment